
The U.S. Supreme Court on Tuesday tossed a $28 million judgment against agricultural biotech company Monsanto, casting deep doubt on the future of lawsuits claiming the herbicide Roundup lacked proper cancer warnings.
The justices granted Monsanto’s petition, vacated a California appellate court ruling that had upheld the award, and sent the case back to state judges for reconsideration. The move follows a significant federal ruling from earlier this year that restricted product liability claims brought under state warning laws.
The California case began in 2021, when Carlsbad resident Mike Dennis sued Monsanto, which was acquired by Bayer, in San Diego Superior Court. Dennis alleged that exposure to Roundup caused him to develop mycosis fungoides, a rare form of non-Hodgkin lymphoma. His lawsuit claimed the manufacturer knew the weedkiller carried cancer risks but sold it without adequate warnings in violation of California law.
A jury originally found Monsanto liable and awarded Dennis $332 million, including $7 million in compensatory damages and $325 million in punitive damages. Although the trial judge refused Monsanto’s request for a new trial, the court reduced the punitive damages to $21 million in 2024 after finding the original sum unconstitutionally excessive. Monsanto appealed, arguing that the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) preempted the failure-to-warn claims, but a California appeals court affirmed the verdict in November 2025.
Source: Courthouse News Service
The Supreme Court’s decision to intervene came after it decided a nearly identical case from Missouri. In that matter, farmer John Durnell sued Monsanto and Bayer in 2019, alleging the companies failed to warn him of cancer risks that led to his non-Hodgkin lymphoma. A Missouri jury awarded Durnell $1.25 million in 2023, and a state appellate panel upheld the award.
The high court heard oral arguments in April and issued a 7-2 ruling in June in favor of Monsanto. Writing for the majority, Justice Brett Kavanaugh stated that the Environmental Protection Agency had repeatedly approved Roundup labels without cancer warnings and determined the product does not cause cancer. Because federal law requires herbicide labels to remain uniform across the country, state laws cannot demand different wording. Kavanaugh wrote that “FIFRA therefore expressly preempts Durnell’s claim.” Justices Ketanji Brown Jackson and Neil Gorsuch dissented.
The high court’s action effectively halts the $28 million California award and directs the state appellate court to revisit the case under the federal preemption standard. A Monsanto spokesperson said the company will urge the California appellate panel to vacate the trial verdict completely. Legal representatives for Dennis could not be reached for comment.
For consumers and agricultural workers, the ruling likely closes future paths for state-law failure-to-warn lawsuits involving Roundup. When a federal agency approves a uniform product label that omits a health warning, plaintiffs may no longer rely on state warning laws to challenge that packaging in court.
Navigating the boundary between federal regulations and state personal injury laws can be complex. When product labeling rules and severe illnesses intersect, consulting an experienced personal injury attorney can help injured individuals evaluate what legal avenues remain available.
The Supreme Court's preemption standard likely closes future state-level failure-to-warn lawsuits against Roundup manufacturers.
The California appellate court must now re-examine the trial court's verdict and determine whether to vacate the remaining award.
Federal regulatory approval of uniform product packaging shields manufacturers from differing state-level disclosure requirements.
Individuals pursuing product liability claims should check whether federal regulatory approval limits their state-law causes of action.
| Case Details | Dennis Lawsuit (California) | Durnell Lawsuit (Missouri) |
|---|---|---|
| Filing Year | 2021 | 2019 |
| Initial Jury Award | $332 million | $1.25 million |
| Modified State Award | $28 million ($21M punitive) | $1.25 million |
| Supreme Court Outcome | Vacated and remanded | Reversed under federal preemption (7-2) |
Source: Courthouse News Service
Federal rules apply nationwide, but your options depend on your state and situation. Browse attorneys by practice area, then pick your state.
This article is general information based on Courthouse News Service and court or agency records available at publication time. It is not legal advice; laws and deadlines differ by state and by case. Published October 13, 2026.
Source: Courthouse News Service
The Supreme Court will decide whether providing everyday essentials like food bars an immigrant from the U.S. under federal material support rules.
New federal rules under the 2025 policy law have cut Medicaid for refugees and trafficking victims, leaving hundreds of thousands without health coverage.
The DOJ announced new emergency scheduling actions for 7‑hydroxymitragynine and three related synthetic opioids, setting concentration thresholds to target high‑potency products.
Lawyers for federal transgender inmates ask the Supreme Court to keep a lower-court order blocking a BOP policy that denies hormone therapy and accommodations.
The Court will hear arguments on whether the 1988 Video Privacy Protection Act can cover modern online newsletters and targeted ads, a case that could reshape digital advertising.